These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35067773)

  • 21. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya.
    Daw MA; El-Bouzedi AH; Ahmed MO
    Front Public Health; 2021; 9():628211. PubMed ID: 34195168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scrutinizing the heterogeneous spreading of COVID-19 outbreak in large territorial countries.
    da Silva RM; Mendes CFO; Manchein C
    Phys Biol; 2021 Feb; 18(2):025002. PubMed ID: 33276353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the shadow of HIV & TB: A commentary on the COVID epidemic in South Africa.
    Bulled N; Singer M
    Glob Public Health; 2020 Aug; 15(8):1231-1243. PubMed ID: 32486906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 calls for health systems strengthening in Africa: A case of Nigeria.
    Elebesunu EE; Oke GI; Adebisi YA; Nsofor IM
    Int J Health Plann Manage; 2021 Nov; 36(6):2035-2043. PubMed ID: 34350637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence.
    Müller SA; Wood RR; Hanefeld J; El-Bcheraoui C
    Health Policy Plan; 2022 Apr; 37(4):505-513. PubMed ID: 34726740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study.
    Zhao S; Peng Z; Wang MH
    Pathog Glob Health; 2022 May; 116(3):137-139. PubMed ID: 34928191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon.
    Nkwayep CH; Bowong S; Tsanou B; Alaoui MAA; Kurths J
    Math Med Biol; 2022 Feb; 39(1):1-48. PubMed ID: 35045180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in different socioeconomic populations in Kuwait: a modeling study.
    Khadadah F; Al-Shammari AA; Alhashemi A; Alhuwail D; Al-Saif B; Alzaid SN; Alahmad B; Bogoch II
    BMC Public Health; 2021 May; 21(1):990. PubMed ID: 34039289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Containment Measures to Control the Spread of COVID-19 in North Africa.
    Ouchetto O; Drissi Bourhanbour A; Boumhamdi M
    Disaster Med Public Health Prep; 2022 Feb; 16(1):201-205. PubMed ID: 32878677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: A Cross-Country Analysis.
    Bouba Y; Tsinda EK; Fonkou MDM; Mmbando GS; Bragazzi NL; Kong JD
    Front Public Health; 2021; 9():751197. PubMed ID: 34746085
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of self-limiting on the prevention and control of the diffuse COVID-19 epidemic with delayed and temporal-spatial heterogeneous.
    Zhu CC; Zhu J
    BMC Infect Dis; 2021 Nov; 21(1):1145. PubMed ID: 34753451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.
    Pons-Salort M; John J; Watson OJ; Brazeau NF; Verity R; Kang G; Grassly NC
    Emerg Infect Dis; 2022 Apr; 28(4):759-766. PubMed ID: 35213800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the Transmission Dynamics of COVID-19 Among Five High Burden African Countries.
    Jemal SS; Alemu BD
    Clin Epidemiol; 2022; 14():1013-1029. PubMed ID: 36051859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
    Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.